SUPN EBITDA Margin
Supernus Pharmaceuticals Inc · EBITDA Margin
SUPN EBITDA Margin
Latest reported-1.91%period ending
SUPN EBITDA Margin (-386.02% → -1.91%)
Annual ebitda margin
High-resolution chart · PNG
SUPN ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 5.916% | |
| 26.9386% | |
| 14.8214% | |
| 22.9837% | |
| 22.2833% | |
| 40.4582% | |
| 45.0288% | |
| 37.0526% | |
| 35.6252% | |
| 26.3322% | |
| 15.0699% | |
| -3.5643% | |
| -696.2476% | |
| -2,826.8919% | |
| -4,573.4745% | |
| -36,118.8679% | |
| 13.7376% | |
| -266.4791% | |
| -386.0204% |